comparemela.com

Latest Breaking News On - Maverick capital ltd - Page 7 : comparemela.com

Achmea Investment Management B V Has $5 16 Million Stake in CBRE Group, Inc (NYSE:CBRE)

Achmea Investment Management B V Has $5 16 Million Stake in CBRE Group, Inc (NYSE:CBRE)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Equitrans Midstream Co (NYSE:ETRN) to Issue $0 15 Quarterly Dividend

Equitrans Midstream Co (NYSE:ETRN) to Issue $0 15 Quarterly Dividend
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Advisor OS LLC Boosts Stake in CBRE Group, Inc (NYSE:CBRE)

Advisor OS LLC Boosts Stake in CBRE Group, Inc (NYSE:CBRE)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Wintrust Financial (NASDAQ:WTFC) Posts Quarterly Earnings Results, Misses Expectations By $0 55 EPS

Wintrust Financial (NASDAQ:WTFC – Get Free Report) released its quarterly earnings results on Wednesday. The bank reported $1.87 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.42 by ($0.55), MarketWatch Earnings reports. Wintrust Financial had a return on equity of 14.14% and a net margin of 20.73%. During the same period […]

Perkins Capital Management Inc Sells 5,100 Shares of ImmunoGen, Inc (NASDAQ:IMGN)

Perkins Capital Management Inc. decreased its position in ImmunoGen, Inc. (NASDAQ:IMGN – Free Report) by 29.7% during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 12,100 shares of the biotechnology company’s stock after selling 5,100 shares during the period. Perkins Capital Management Inc.’s holdings in ImmunoGen were […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.